1. Global Markets for Contract Pharmaceutical Manufacturing, Research and
Packaging: Focus on Europe
Published:September2011
Price:US $ 4850
Report Summary
* The global pharmaceutical contract manufacturing and contract research
organizations revenue reached at $196.5 billion in 2010, it will further grow
to $217.9 billion in 2011 and is projected to reach at $360.6 billion by 2016,
increasing at a compound annual growth rate (CAGR) of 10.6%.
* The European contract manufacturing market for OTC and nutritional
products was valued at about $46.0 billion in 2010 and is projected to reach
approximately $51.3 in 2011 and it will further grow to $86.5 billion by
2016, at a compound annual growth rate (CAGR) of 11%.
* The contract research market revenue for Europe in 2009 was $5.8 billion,
which reached $6.3 billion in 2010. This market is expected to reach at $6.9
billion in 2011 and it will further grow to $10.5 billion by 2016, at a
compound annual growth rate (CAGR) of 8.7%.
Browse All Pharmaceuticals Market Research Reports
Table Of Contents
CHAPTER ONE: INTRODUCTION
STUDY OBJECTIVE
REASONS FOR DOING THIS STUDY
INTENDED AUDIENCE
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ABOUT THE AUTHOR
RELATED BCC RESEARCH REPORTS
BCC ONLINE SERVICES
DISCLAIMER
CHAPTER TWO: SUMMARY
SUMMARY
SUMMARY (CONTINUED)

2. SUMMARY TABLE GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING
AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2016 ($
BILLIONS)
SUMMARY FIGURE GLOBAL PHARMACEUTICAL CONTRACT
MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE,
2009-2016 ($ BILLIONS)
CHAPTER THREE: OVERVIEW
DEFINITIONS
DEFINITIONS (CONTINUED)
HISTORY OF OUTSOURCING
TABLE 1 KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCING
TABLE 1 (CONTINUED)
CHAPTER FOUR: OVERVIEW OF CONTRACT MANUFACTURING
TYPES OF CONTRACT MANUFACTURERS
CONTRACT MANUFACTURING TRAITS
REQUIREMENT
ABILITY TO BE FLEXIBLE
CAPABILITIES WITHOUT COST
ADVANTAGES AND DISADVANTAGES OF CONTRACT MANUFACTURING
TABLE 2 KEY ADVANTAGES OF CONTRACT MANUFACTURING
TABLE 3 KEY DISADVANTAGES OF CONTRACT MANUFACTURING
SELECTING A CONTRACT MANUFACTURER
TABLE 4 KEY FACTORS IN SELECTING A CONTRACT MANUFACTURER
TABLE 4 (CONTINUED)
ADDITIONAL FACTS ABOUT CONTRACT MANUFACTURING
LOCATION AND PROXIMITY
AFTER-SALES SUPPORT
CHAPTER FIVE: OVERVIEW OF CONTRACT RESEARCH
OVERVIEW OF CONTRACT RESEARCH
SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATIONS
TABLE 5 SERVICES OF CONTRACT RESEARCH ORGANIZATIONS
TABLE 5 (CONTINUED)
SELECTING A CONTRACT RESEARCH ORGANIZATION
TABLE 6 KEY CHARACTERISITCS IN SELECTING A CONTRACT RESEARCH
ORGANIZATION
TABLE 6 (CONTINUED)
RESEARCH PROVIDED BY CONTRACT RESEARCH ORGNIZATIONS
TABLE 7 TYPES OF RESEARCH PROVIDED BY CONTRACT RESEARCH
ORGANIZATIONS
TABLE 7 (CONTINUED)

3. CHAPTER SIX: OVERVIEW OF CONTRACT PACKAGING
NEEDING A CONTRACT PACKAGER
TABLE 8 REASONS BEHIND NEEDING A CONTRACT PACKAGER
TABLE 8 (CONTINUED)
SELECTING A CONTRACT PACKAGER
TABLE 9 KEY CHARACTERISTICS IN SELECTING A CONTRACT PACKAGER
HIRING A CONTRACT PACKAGER
TABLE 10 KEY STEPS IN HIRING A CONTRACT PACKAGER
TYPES OF PACKAGING
TYPES OF PACKAGING (CONTINUED)
CHAPTER SEVEN: PROJECT MANAGEMENT
SPECIFICATIONS OF PROJECT MANAGEMENT
TABLE 11 STEPS OF PROJECT MANAGEMENT
TABLE 11 (CONTINUED)
PROCESSES OF PROJECT MANAGEMENT
TABLE 12 PROCESSES OF PROJECT MANAGEMENT
TABLE 12 (CONTINUED)
FACTORS INVOLVED
ROLE OF THE PROJECT MANAGER
TABLE 13 KEY RESPONSIBILITIES OF PROJECT MANAGERS
TECHNOLOGY TRANSFER
TABLE 14 TECHNOLOGY TRANSFER STEPS
CHAPTER EIGHT: REGULATORY ASPECTS
REGULATORY ASPECTS
TABLE 15 REGULATED FACTORS OF CMO’S AND CRO’S
TABLE 16 TITLE 21 CFR RULES ASSOCIATED WITH CONTRACT
MANUFACTURING
TABLE 16 (CONTINUED)
TABLE 16 (CONTINUED)
WARNING LETTERS
TABLE 17 WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS,
2010
TABLE 18 WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS,
2009
REGULATORY APPROVALS
TABLE 19 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND
FACILITIES, JANUARY THROUGH MARCH, 2011
TABLE 20 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND
FACILITIES, 2010
TABLE 20 (CONTINUED)
TABLE 21 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND

4. FACILITIES, 2009
TABLE 21 (CONTINUED)
CHAPTER NINE: INDUSTRY STRUCTURE FOR EUROPE
MARKET SHARE OF INDUSTRY LEADERS
CONTRACT MANUFACTURERS OF BULK DRUGS AND API’S
TABLE 22 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING BULK DRUGS/API’S, IN EUROPE, 2010 (%)
TABLE 22 (CONTINUED)
FIGURE 1 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING BULK DRUGS/API’S, IN EUROPE, 2010 (%)
CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS
TABLE 23 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SOLID DOSAGE FORMS, IN EUROPE, 2010 (%)
FIGURE 2 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SOLID DOSAGE FORMS, IN EUROPE, 2010 (%)
CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS
NONSTERILE
TABLE 24 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING NONSTERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010 (%)
FIGURE 3 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING NONSTERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010 (%)
STERILE
TABLE 25 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING STERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010 (%)
FIGURE 4 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING STERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010 (%)
CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS
TABLE 26 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SEMISOLID DOSAGE FORMS, IN EUROPE, 2010 (%)
FIGURE 5 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SEMISOLID DOSAGE FORMS, IN EUROPE, 2010 (%)
CONTRACT RESEARCH COMPANIES
TABLE 27 MARKET SHARE OF CONTRACT RESEARCH COMPANIES, IN
EUROPE, 2010 (%)
FIGURE 6 MARKET SHARE OF CONTRACT RESEARCH COMPANIES, IN
EUROPE, 2010 (%)
TABLE 28 MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN
EUROPE, 2010 (%)
FIGURE 7 MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN
EUROPE, 2010 (%)

5. CHAPTER TEN: TECHNOLOGY TRANSFER
REASONS FOR TECHNOLOGY TRANSFER
CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER
TECHNOLOGY TRANSFER
STEPS FOR SUCCESSFUL TECHNOLOGY TRANSFER
TYPES OF CONTRACTUAL AGREEMENTS USED IN TECHNOLOGY TRANSFER
CONFIDENTIAL DISCLOSURE AGREEMENT (CDA)
MATERIAL TRANSFER AGREEMENT (MTA)
ASSIGNMENT DEED
LICENSE AGREEMENT
CO-DEVELOPMENT AND CO-MARKETING AGREEMENTS
CHARACTERISTICS OF A SUCCESSFUL PROJECT
CHARACTERISTICS OF A SUCCESSFUL … (CONTINUED)
CHAPTER ELEVEN: NEW DEVELOPMENTS
LONZA
ABBOTT
HOSPIRA
COVIDIEN
OTHER
OTHER (CONTINUED)
CHAPTER TWELVE: MARKET ANALYSIS FOR EUROPE
CONTRACT MANUFACTURING
CONTRACT MANUFACTURE OF BULK DRUGS/API’S
Market Overview
Market Revenue
TABLE 29 BULK DRUG/API CONTRACT MANUFACTURING REVENUE, FOR
EUROPE, THROUGH 2016 ($ BILLIONS)
FIGURE 8 BULK DRUG/API CONTRACT MANUFACTURING REVENUE, FOR
EUROPE, 2009-2016 ($ BILLIONS)
CONTRACT MANUFACTURE OF ORAL DOSAGE FORMULATIONS
Solid Dosage Formulations
Market Overview
Market Revenue
TABLE 30 SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR
EUROPE, THROUGH 2016 ($ BILLIONS)
FIGURE 9 SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR
EUROPE, 2009- 2016 ($ BILLIONS)
Market by Formulation
Market Revenue
TABLE 31 SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE,

6. BY FORMULATION, FOR EUROPE, THROUGH 2016 ($ BILLIONS)
FIGURE 10 SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE,
BY FORMULATIONS, FOR EUROPE, 2009-2016 ($ BILLIONS)
TABLE 32 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET
SHARES, BY FORMULATION, FOR EUROPE, 2010 (%)
FIGURE 11 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET
SHARES, BY FORMULATIONS, FOR EUROPE, 2010 (%)
Liquid Dosage Formulation
Market Overview
Market Revenue
Nonsterile Formulations
TABLE 33 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING, FOR EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 12 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING, FOR EUROPE, 2009-2016 ($ MILLIONS)
Sterile Formulations
TABLE 34 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING,
FOR EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 13 LIQUID DOSAGE FORM (STERILE) CONTRACT
MANUFACTURING, FOR EUROPE, 2009-2016 ($ MILLIONS)
Market by Formulation
Nonsterile Formulations
TABLE 35 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE, THROUGH
2016 ($ MILLIONS)
FIGURE 14 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016
($ MILLIONS)
TABLE 36 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING MARKET SHARES, BY FORMULATION, FOR EUROPE, 2010
(%)
FIGURE 15 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING MARKET SHARES, BY FORMULATIONS, FOR EUROPE,
2010 (%)
Sterile Formulations
TABLE 37 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 16 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR EUROPE, 2009-2016 ($ MILLIONS)
TABLE 38 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR EUROPE, 2010 (%)
FIGURE 17 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATIONS, FOR EUROPE, 2010 (%)

7. CONTRACT MANUFACTURE OF SEMISOLID DOSAGE FORMULATIONS
Market Overview
Market Revenue
TABLE 39 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR
EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 18 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR
EUROPE, 2009-2016 ($ MILLIONS)
TABLE 40 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 19 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING
REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016 ($ MILLIONS)
TABLE 41 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR EUROPE, 2010 (%)
FIGURE 20 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATIONS, FOR EUROPE, 2010 (%)
CONTRACT MANUFACTURE OF ADVANCED DRUG DELIVERY PRODUCTS
Market Overview
TABLE 42 CONTRACTING COMPANIES PROVIDING DRUG DELIVERY
SYSTEMS
Market Revenue
TABLE 43 ADVANCED DRUG DELIVERY SYSTEMS REVENUE, BY CONTRACT
MANUFACTURING, FOR EUROPE, THROUGH 2016 ($ BILLIONS)
FIGURE 21 ADVANCED DRUG DELIVERY SYSTEMS REVENUE, BY CONTRACT
MANUFACTURING, FOR EUROPE, 2009-2016 ($ BILLIONS)
Market by Formulation
TABLE 44 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT
MANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE, THROUGH
2016 ($ MILLIONS)
FIGURE 22 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT
MANUFACTURING REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016
($ MILLIONS)
Market Share
TABLE 45 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATION, FOR EUROPE, 2010
(%)
FIGURE 23 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR EUROPE, 2010
(%)
CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL PRODUCTS
Market Revenue
TABLE 46 OTC AND NUTRITIONAL PRODUCTS REVENUE, BY CONTRACT
MANUFACTURING, FOR EUROPE, THROUGH 2016 ($ BILLIONS)
FIGURE 24 OTC AND NUTRITIONAL PRODUCTS REVENUE, BY CONTRACT

8. MANUFACTURING, FOR EUROPE, 2009-2016 ($ BILLIONS)
Market by Formulation
TABLE 47 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT
MANUFACTURING REVENUE, BY FORMULATION, FOR EUROPE, THROUGH
2016 ($ BILLIONS)
FIGURE 25 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT
MANUFACTURING REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016
($ BILLIONS)
Market Shares
TABLE 48 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATION, FOR EUROPE, 2010
(%)
FIGURE 26 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT
MANUFACTURING MARKET SHARE, BY FORMULATIONS, FOR EUROPE, 2010
(%)
CONTRACT RESEARCH
MARKET OVERVIEW
Partnerships
Expansions of Facilities
Market Revenue
TABLE 49 CONTRACT RESEARCH REVENUE, FOR EUROPE, THROUGH 2016
($ BILLIONS)
FIGURE 27 CONTRACT RESEARCH REVENUE, FOR EUROPE, 2009-2016 ($
BILLIONS)
Market by Discipline
TABLE 50 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR EUROPE,
THROUGH 2016 ($ MILLIONS)
FIGURE 28 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR EUROPE,
2009-2016 ($ MILLIONS)
Market Share by Discipline
TABLE 51 CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOR
EUROPE, 2010 (%)
FIGURE 29 CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOR
EUROPE, 2010 (%)
CONTRACT PACKAGING
MARKET OVERVIEW
Market Revenue
TABLE 52 CONTRACT PACKAGING REVENUE, FOR EUROPE, THROUGH 2016
($ BILLIONS)
FIGURE 30 CONTRACT PACKAGING REVENUE, FOR EUROPE, 2009-2016 ($
BILLIONS)
Market by Package Type
TABLE 53 CONTRACT PACKAGING REVENUE BY TYPE, FOR EUROPE,

9. THROUGH 2016 ($ MILLIONS)
FIGURE 31 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR EUROPE,
2009-2016 ($ BILLIONS)
Market Share by Type
TABLE 54 CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR EUROPE,
2010 (%)
FIGURE 32 CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR EUROPE,
2010 (%)
CHAPTER THIRTEEN: MARKET SHARE BY REGION
MARKET SHARE OF CONTRACT MANUFACTURED API’S
TABLE 55 BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARE,
BY REGION, 2010 (%)
FIGURE 33 BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARE,
BY REGION, 2010 (%)
MARKET SHARE OF CONTRACT MANUFACTURED SOLID DOSAGE FORMS
TABLE 56 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET
SHARE, BY REGION, 2010 (%)
FIGURE 34 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET
SHARE, BY REGION, 2010 (%)
MARKET SHARE OF CONTRACT MANUFACTURED LIQUID DOSAGE
FORMULATIONS
NONSTERILE FORMULATIONS
TABLE 57 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING MARKET SHARE, BY REGION, 2010 (%)
FIGURE 35 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT
MANUFACTURING MARKET SHARE, BY REGION, 2010 (%)
STERILE FORMULATIONS
TABLE 58 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%)
FIGURE 36 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%)
MARKET SHARE OF CONTRACT MANUFACTURED SEMISOLID DOSAGE
FORMULATIONS
TABLE 59 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING
MARKET SHARES, BY REGION, 2010 (%)
FIGURE 37 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%)
MARKET SHARE OF CONTRACT MANUFACTURED ADVANCED DRUG
DELIVERY PRODUCTS
TABLE 60 DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARE,
BY REGION, 2010 (%)
FIGURE 38 DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARE,

10. BY REGION, 2010 (%)
MARKET SHARE OF CONTRACT MANUFACTURED OTC AND NUTRITIONAL
PRODUCTS
TABLE 61 OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%)
FIGURE 39 OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%)
MARKET SHARE OF CONTRACT RESEARCH
TABLE 62 CONTRACT RESEARCH MARKET SHARE, BY REGION, 2010 (%)
FIGURE 40 CONTRACT RESEARCH MARKET SHARE, BY REGION, 2010 (%)
MARKET SHARE OF CONTRACT PACKAGING
TABLE 63 CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010 (%)
FIGURE 41 CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010
(%)
CHAPTER FOURTEEN: CONTRACT MANUFACTURING APPLICATIONS
FOR EUROPEAN MARKETS
CARDIOVASCULAR DRUGS
MARKET REVENUE
TABLE 64 REVENUE FROM CONTRACT MANUFACTURERS OF
CARDIOVASCULAR DRUGS, IN EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 42 REVENUE FROM CONTRACT MANUFACTURERS OF
CARDIOVASCULAR DRUGS, IN EUROPE, 2009-2016 ($ MILLIONS)
REPRODUCTIVE DRUG MARKET
MARKET REVENUE
TABLE 65 REVENUE FROM CONTRACT MANUFACTURERS OF
REPRODUCTIVE DRUGS, IN EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 43 REVENUE FROM CONTRACT MANUFACTURERS OF
REPRODUCTIVE DRUGS, IN EUROPE, 2009-2016 ($ MILLIONS)
ONCOLOGY DRUG MARKET
MARKET REVENUE
TABLE 66 REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGY
DRUGS, IN EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 44 REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGY
DRUGS, IN EUROPE, 2009-2016 ($ MILLIONS)
ANALGESICS MARKET
MARKET REVENUE
TABLE 67 REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS,
IN EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 45 REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS,
IN EUROPE, 2009-2016 ($ MILLIONS)
ANTIVIRAL DRUG MARKET
MARKET REVENUE

11. TABLE 68 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS,
IN EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 46 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS,
IN EUROPE, 2009-2016 ($ MILLIONS)
ANTIBIOTICS MARKET
MARKET REVENUE
TABLE 69 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS,
IN EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 47 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS,
IN EUROPE, 2009-2016 ($ MILLIONS)
MARKETS FOR OTHER DRUGS
MARKET REVENUE
TABLE 70 REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS,
IN EUROPE, THROUGH 2016 ($ BILLIONS)
FIGURE 48 REVENUE FROM CONTRACT MANUFACTURERS OF OTHER
DRUGS, IN EUROPE, 2009-2016 ($ BILLIONS)
CHAPTER FIFTEEN: PATENT ANALYSIS
PATENTS BY YEAR
TABLE 71 NUMBER OF SIGNIFICANT PATENTS, BY YEAR, 2009-2011
FIGURE 49 NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011
FIGURE 50 NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011 (%)
PATENTS BY COMPANY
TABLE 72 NUMBER OF U.S. PATENTS, BY COMPANY, 2009-2011
FIGURE 51 NUMBER OF U.S. PATENTS, BY COMPANY, 2009-2011
PATENTS BY COUNTRY
TABLE 73 NUMBER OF U.S. PATENTS, BY COUNTRY, 1/1/2009 TO
5/31/2011
FIGURE 52 NUMBER OF U.S. PATENTS, BY COUNTRY, 1/1/2009 TO
5/31/2011
TABLE 74 PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011 (%)
FIGURE 53 PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011 (%)
PATENTS BY EMPHASIS
TABLE 75 PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011
FIGURE 54 NUMBER OF U.S. PATENTS, BY EMPHASIS, 1/1/2009 TO
5/31/2011
CHAPTER SIXTEEN: CURRENT ENVIRONMENT
SITUATION OF THE NORTH AMERICAN CONTRACTING MARKETS
CONTRACT MANUFACTURING OF API AND DOSAGE FORMS
CONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALS
CONTRACT RESEARCH
CONTRACT PACKAGING

12. SITUATION OF THE EUROPEAN CONTRACTING MARKET
CONTRACT MANUFACTURING OF API AND DOSAGE FORMS
CONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALS
CONTRACT RESEARCH
CONTRACT PACKAGING
SITUATION OF THE ROW CONTRACTING MARKET
CONTRACT MANUFACTURING OF API AND DOSAGE FORMS
CONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALS
CONTRACT RESEARCH
CONTRACT PACKAGING
OPPORTUNITIES AND CHALLENGES OF THE CURRENT CONTRACT
MANUFACTURING INDUSTRY
OPPORTUNITIES AND CHALLENGES…(CONTINUED)
OPPORTUNITIES AND CHALLENGES…(CONTINUED)
CHAPTER SEVENTEEN: COMPANY PROFILES
AAI PHARMA, INC.
ABBOTT LABORATORIES
AEROGEN LTD.
ALKERMES
ALTHEA TECHNOLOGIES
AMCOR
AMERISOURCE BERGEN CORPORATION
AMPAC FINE CHEMICALS
ALBANY MOLECULAR RESEARCH INC. (AMRI)
AP PHARMA INC.
APTUIT INC.
ARADIGM CORPORATION
BASF SE
BAXTER HEALTHCARE
BCM/BOOTS MANUFACTURING
BOEHRINGER INGELHEIM
BRISTOL-MYERS SQUIBB
CAMBREX CORPORATION
CANGENE CORPORATION
CATALENT PHARMA SOLUTIONS
CEDARBURG HAUSER PHARMACEUTICALS INC.
CENEXI
CHARLES RIVER LABORATORIES
CHEMBRIDGE CORP.
CLEARSTONE CENTRAL LABORATORIES
CONFAB LABORATORIES
COVANCE INC.

13. COVIDIEN
CONTRACT PHARMACEUTICALS LIMITED
CORDEN PHARMA SWITZERLAND LLC
DAVOS PHARMA
DECODE GENETICS
DISHMAN PHARMACEUTICALS AND CHEMICALS LTD.
DOW CHEMICAL
DPT LABORATORIES INC.
DR. REDDY’S LABORATORIES
DSM PHARMACEUTICAL PRODUCTS
FUJIFILM DIOSYNTH BIOTECHNOLOGY
ELAN DRUG TECHNOLOGIES
EVOTEC AG
FULCRUM PHARMA PLC
GIRINDUS AG
GLAXOSMITHKLINE
HOSPIRA
HAUPT PHARMA AG
HOVIONE S.A
ICON PLC
INC RESEARCH, INC.
JUBILANT LIFESCIENCES
KENDLE INTERNATIONAL INC.
KP PHARMACEUTICAL TECHNOLOGIES INC.
K.V. PHARMACEUTICAL CO.
LIGAND PHARMACEUTICALS, INC.
LONZA GROUP
LYNE LABORATORIES
MERCK / MSD BIOMANUFACTURING NETWORK
MIKART INC
NEXTPHARMA TECHNOLOGIES
NORWICH PHARMACEUTICALS
NOVAVAX, INC.
OMNICARE CLINICAL RESEARCH
PAREXEL INTERNATIONAL CORPORATION
PATHEON INC.
PERRIGO COMPANY
PFIZER (KING PHARMACEUTICALS
PIRAMAL HEALTHCARE LIMITED
PPD
PRA INTERNATIONAL
QUINTILES
RANBAXY

14. REGIS TECHNOLOGIES, INC.
SKYEPHARMA
TALECRIS BIOTHERAPEUTICS INC.
VETTER PHARMA INTERNATIONAL GMBH
WOCKHARDT LIMITED
WUXI APP TEC
XCELLEREX LLC
ZACH SYSTEM S.P.A
APPENDIX I: ABBREVIATIONS
About Us:
ReportsnReports is an online library of over 100,000+ market research
reports and in-depth market research studies & analysis of over 5000 micro
markets. We provide 24/7 online and offline support to our customers. Get
in touch with us for your needs of market research reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page:
http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Visit our Market Research Blog